Literature DB >> 20188592

Anesthesia and perioperative management of patients undergoing transcatheter aortic valve implantation: analysis of 90 consecutive patients with focus on perioperative complications.

Pierre-Grégoire Guinot1, Jean-Pol Depoix, Laure Etchegoyen, Abdel Benbara, Sophie Provenchère, Marie-Pierre Dilly, Ivan Philip, Daniel Enguerand, Hassan Ibrahim, Alec Vahanian, Dominique Himbert, Nawaar Al-Attar, Patrick Nataf, Jean-Marie Desmonts, Philippe Montravers, Dan Longrois.   

Abstract

OBJECTIVE: To describe, from the point of view of anesthesia and intensive care specialists, the perioperative management of high-risk patients with aortic stenosis who underwent transcatheter (transfemoral and transapical) aortic valve implantation (TAVI). The authors specifically focused on immediate postoperative complications.
DESIGN: Retrospective review of collected data.
SETTING: Academic hospital. PARTICIPANTS: Ninety consecutive patients with severe aortic stenosis who underwent TAVI.
INTERVENTIONS: General anesthesia followed by postoperative care. Complications were defined by pre-established criteria.
MEASUREMENTS AND MAIN RESULTS: Of 184 patients referred between October 2006 and February 2009, 90 were consecutively treated with TAVI because of a high surgical risk or contraindications to surgery. The transfemoral approach was used as the first option (n = 62), and the transapical approach when contraindications to the former were present (n = 28). Results are presented as mean ± standard deviation or median (25-75 percentiles) as appropriate. Patients were 81 ± 8 years old, in New York Heart Association classes II (9%), III (54 %), or IV (37%); left ventricular ejection fraction was below 0.5 in 38% of patients. The predicted surgical mortality was 24% (16-32) and 15% (11-23) with the logistic EuroSCORE and STS-Predicted Risk of Mortality, respectively. The valve was implanted in 92% of the cases. The duration of anesthesia and (intra- and postoperative) mechanical ventilation was 190 (160-230) minutes and 245 (180-420) minutes, respectively. Hospital mortality was 11%. The most frequent cardiac complications were heart failure (20%) and atrioventricular block (16%), with 6% requiring a pacemaker. Vascular complications (major and minor) occurred in 29% of the patients.
CONCLUSIONS: Despite their severe comorbidities, the mortality of the patients in this cohort was below that predicted by cardiac surgery risk scores. Monitoring, hemodynamic instability, and the frequency of complications require management and follow-up of these patients in similar ways as for open cardiac surgery. The frequency of complications in this cohort was comparable to that published by other groups.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20188592     DOI: 10.1053/j.jvca.2009.12.019

Source DB:  PubMed          Journal:  J Cardiothorac Vasc Anesth        ISSN: 1053-0770            Impact factor:   2.628


  13 in total

Review 1.  [Transcatheter aortic valve implantation : what do anesthetists need to know?].

Authors:  C Riediger; F Nietlispach; F Rüter; J Fassl
Journal:  Anaesthesist       Date:  2011-12       Impact factor: 1.041

2.  A systematic review of transapical aortic valve implantation.

Authors:  Mohammad Rahnavardi; Jaime Santibanez; Karan Sian; Tristan D Yan
Journal:  Ann Cardiothorac Surg       Date:  2012-07

Review 3.  Vascular approaches for transcatheter aortic valve implantation.

Authors:  Isaac Pascual; Amelia Carro; Pablo Avanzas; Daniel Hernández-Vaquero; Rocío Díaz; Jose Rozado; Rebeca Lorca; María Martín; Jacobo Silva; César Morís
Journal:  J Thorac Dis       Date:  2017-05       Impact factor: 2.895

4.  Transcatheter aortic valve implantation under conscious sedation - the first Indian experience.

Authors:  Syed Maqbool; Vijay Kumar; Vishal Rastogi; Ashok Seth
Journal:  Indian Heart J       Date:  2014-03-02

5.  Bispectral index-guided sedation in transfemoral transcatheter aortic valve implantation: a retrospective control study.

Authors:  Wei He; Rong-Rong Huang; Qing-Yu Shi; Xian-Bao Liu; Jian-An Wang; Min Yan
Journal:  J Zhejiang Univ Sci B       Date:  2017 Apr.       Impact factor: 3.066

6.  Transcatheter Aortic Valve Implantation: First Applications and Short Term Outcomes in Our Clinic.

Authors:  Mehmet Aksoy; Ilker Ince; Ali Ahiskalioglu; Nazim Dogan; Abdurrahim Colak; Serdar Sevimli
Journal:  Eurasian J Med       Date:  2015-06

7.  Advanced 3D Mesh Manipulation in Stereolithographic Files and Post-Print Processing for the Manufacturing of Patient-Specific Vascular Flow Phantoms.

Authors:  Ryan P O'Hara; Arpita Chand; Sowmya Vidiyala; Stacie M Arechavala; Dimitrios Mitsouras; Stephen Rudin; Ciprian N Ionita
Journal:  Proc SPIE Int Soc Opt Eng       Date:  2016-03-25

8.  Treatment Planning for Image-Guided Neuro-Vascular Interventions Using Patient-Specific 3D Printed Phantoms.

Authors:  M Russ; R O'Hara; S V Setlur Nagesh; M Mokin; C Jimenez; A Siddiqui; D Bednarek; S Rudin; C Ionita
Journal:  Proc SPIE Int Soc Opt Eng       Date:  2015-03-19

9.  Major themes for 2009 in cardiothoracic and vascular anesthesia.

Authors:  J Fassl; H Riha; H Ramakrishna; N Singh; T Wyckoff; C Roscher; J G T Augoustides
Journal:  HSR Proc Intensive Care Cardiovasc Anesth       Date:  2010

10.  Paravertebral analgesia in transapical transcatheter aortic valve replacement.

Authors:  Justin M Poltak; Frederick C Cobey; John G Augoustides; Christopher W Connors
Journal:  Heart Lung Vessel       Date:  2015
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.